Last Updated: 02/03/2018
Performance of the HRP2-based ultrasensitive RDT: Field studies
Objectives
Main objectives:
- Show how and where highly-sensitive RDTs provide added value over current tests
- Performance in the field
- Sensitivity improvements over current RDTs
- Cost and point of care advantages over PCR
- Provide a tool to perform a real assessment of screen & test versus MDA
- Test and treat has not been effectively compared to MDA due to an absence of appropriate tools
- PCR was not performed at the point of care level results in delays in treatment
- Help define guidance on elimination and surveillance strategies
Centers for Disease Control and Prevention (CDC), United States
Swiss Tropical and Public Health Institute (Swiss TPH), Switzerland
Mahidol Oxford Tropical Medicine Research Unit (MORU), Thailand
QIMR Berghofer Medical Research, Australia
London School of Hygiene and Tropical Medicine (LSHTM), United Kingdom
Liverpool School of Tropical Medicine (LSTM), United Kingdom
Barcelona Institute for Global Health (ISGlobal), Spain
Manhiça Health Research Centre (CISM), Mozambique
Highly-sensitive RDT evaluation study in Myanmar
Evaluating the performance of an ultra-sensitive rapid diagnostic test (uRDT) to detect asymptomatic malaria infections in the low transmission setting of Zambezi Region, Namibia
Highly-sensitive RDT evaluation study in Kenya
Highly-sensitive RDT evaluation study in Haiti
Highly-sensitive RDT evaluation study in Mozambique